865 related articles for article (PubMed ID: 12036919)
61. TRAIL induces apoptosis and activation of NFkappaB.
Jeremias I; Debatin KM
Eur Cytokine Netw; 1998 Dec; 9(4):687-8. PubMed ID: 9889416
[TBL] [Abstract][Full Text] [Related]
62. Interferon-gamma modulates TRAIL-mediated apoptosis in human colon carcinoma cells.
Langaas V; Shahzidi S; Johnsen JI; Smedsrød B; Sveinbjørnsson B
Anticancer Res; 2001; 21(6A):3733-8. PubMed ID: 11911240
[TBL] [Abstract][Full Text] [Related]
63. Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D.
Mori S; Murakami-Mori K; Nakamura S; Ashkenazi A; Bonavida B
J Immunol; 1999 May; 162(9):5616-23. PubMed ID: 10228045
[TBL] [Abstract][Full Text] [Related]
64. Differential expression of members of the tumor necrosis factor alpha-related apoptosis-inducing ligand pathway in prostate cancer cells.
Sridhar S; Ali AA; Liang Y; El Etreby MF; Lewis RW; Kumar MV
Cancer Res; 2001 Oct; 61(19):7179-83. PubMed ID: 11585752
[TBL] [Abstract][Full Text] [Related]
65. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
[TBL] [Abstract][Full Text] [Related]
66. Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells.
Lee YJ; Lee KH; Kim HR; Jessup JM; Seol DW; Kim TH; Billiar TR; Song YK
Oncogene; 2001 Mar; 20(12):1476-85. PubMed ID: 11313891
[TBL] [Abstract][Full Text] [Related]
67. Expression and antitumor effects of TRAIL in human cholangiocarcinoma.
Tanaka S; Sugimachi K; Shirabe K; Shimada M; Wands JR
Hepatology; 2000 Sep; 32(3):523-7. PubMed ID: 10960444
[TBL] [Abstract][Full Text] [Related]
68. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells.
Nesterov A; Ivashchenko Y; Kraft AS
Oncogene; 2002 Feb; 21(7):1135-40. PubMed ID: 11850832
[TBL] [Abstract][Full Text] [Related]
69. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis.
Roth W; Wagenknecht B; Klumpp A; Naumann U; Hahne M; Tschopp J; Weller M
Cell Death Differ; 2001 Apr; 8(4):403-10. PubMed ID: 11550092
[TBL] [Abstract][Full Text] [Related]
70. Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection.
Clarke P; Meintzer SM; Spalding AC; Johnson GL; Tyler KL
Oncogene; 2001 Oct; 20(47):6910-9. PubMed ID: 11687970
[TBL] [Abstract][Full Text] [Related]
71. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
[TBL] [Abstract][Full Text] [Related]
72. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
Kayagaki N; Yamaguchi N; Nakayama M; Kawasaki A; Akiba H; Okumura K; Yagita H
J Immunol; 1999 Mar; 162(5):2639-47. PubMed ID: 10072506
[TBL] [Abstract][Full Text] [Related]
73. Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative.
Wajant H; Moosmayer D; Wüest T; Bartke T; Gerlach E; Schönherr U; Peters N; Scheurich P; Pfizenmaier K
Oncogene; 2001 Jul; 20(30):4101-6. PubMed ID: 11494138
[TBL] [Abstract][Full Text] [Related]
74. Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.
Oshima K; Yanase N; Ibukiyama C; Yamashina A; Kayagaki N; Yagita H; Mizuguchi J
Cytokine; 2001 May; 14(4):193-201. PubMed ID: 11448118
[TBL] [Abstract][Full Text] [Related]
75. Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis.
Inoue H; Shiraki K; Ohmori S; Sakai T; Deguchi M; Yamanaka T; Okano H; Nakano T
Int J Mol Med; 2002 May; 9(5):521-5. PubMed ID: 11956660
[TBL] [Abstract][Full Text] [Related]
76. Apoptosis-induced by TRAIL AND TNF-alpha in human multiple myeloma cells is not blocked by BCL-2.
Gazitt Y; Shaughnessy P; Montgomery W
Cytokine; 1999 Dec; 11(12):1010-9. PubMed ID: 10623426
[TBL] [Abstract][Full Text] [Related]
77. Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
Grotzer MA; Eggert A; Zuzak TJ; Janss AJ; Marwaha S; Wiewrodt BR; Ikegaki N; Brodeur GM; Phillips PC
Oncogene; 2000 Sep; 19(40):4604-10. PubMed ID: 11030149
[TBL] [Abstract][Full Text] [Related]
78. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
Oya M; Ohtsubo M; Takayanagi A; Tachibana M; Shimizu N; Murai M
Oncogene; 2001 Jun; 20(29):3888-96. PubMed ID: 11439352
[TBL] [Abstract][Full Text] [Related]
79. Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.
Scheltema JM; Romijn JC; van Steenbrugge GJ; Schröder FH; Mickisch GH
Anticancer Res; 2001; 21(5):3161-6. PubMed ID: 11848468
[TBL] [Abstract][Full Text] [Related]
80. Bcl-2 over-expression and activation of protein kinase C suppress the trail-induced apoptosis in Jurkat T cells.
Guo BC; Xu YH
Cell Res; 2001 Jun; 11(2):101-6. PubMed ID: 11453541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]